BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27464683)

  • 1. Human Respiratory Syncytial Virus: An Introduction.
    Jorquera PA; Anderson L; Tripp RA
    Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host response and molecular pathogenesis associated with respiratory syncytial virus infection.
    Oshansky CM; Zhang W; Moore E; Tripp RA
    Future Microbiol; 2009 Apr; 4(3):279-97. PubMed ID: 19327115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the host immune response by respiratory syncytial virus proteins.
    Schmidt ME; Varga SM
    J Microbiol; 2017 Mar; 55(3):161-171. PubMed ID: 28243940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.
    San-Juan-Vergara H; Peeples ME
    Immunol Allergy Clin North Am; 2019 Aug; 39(3):321-334. PubMed ID: 31284923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.
    Boyoglu-Barnum S; Chirkova T; Anderson LJ
    Front Immunol; 2019; 10():1675. PubMed ID: 31402910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
    Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
    PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
    Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
    J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.
    Whelan JN; Tran KC; van Rossum DB; Teng MN
    J Virol; 2016 Jul; 90(14):6453-6463. PubMed ID: 27147743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.
    Collins PL; Melero JA
    Virus Res; 2011 Dec; 162(1-2):80-99. PubMed ID: 21963675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
    J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and epidemiologic features of respiratory syncytial virus.
    Hall CB; Simőes EA; Anderson LJ
    Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus.
    Lay MK; Bueno SM; Gálvez N; Riedel CA; Kalergis AM
    Crit Rev Microbiol; 2016 Sep; 42(5):800-12. PubMed ID: 26119025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure.
    Grad YH; Newman R; Zody M; Yang X; Murphy R; Qu J; Malboeuf CM; Levin JZ; Lipsitch M; DeVincenzo J
    J Virol; 2014 Jul; 88(13):7286-93. PubMed ID: 24741088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
    Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.
    González PA; Bueno SM; Riedel CA; Kalergis AM
    Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    Li Z; Qu X; Liu X; Huan C; Wang H; Zhao Z; Yang X; Hua S; Zhang W
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adaptive immune response to respiratory syncytial virus.
    Varga SM; Braciale TJ
    Curr Top Microbiol Immunol; 2013; 372():155-71. PubMed ID: 24362689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.
    Harris J; Werling D
    Cell Microbiol; 2003 Oct; 5(10):671-80. PubMed ID: 12969373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of host adaptive immunity by hRSV proteins.
    Espinoza JA; Bohmwald K; Céspedes PF; Riedel CA; Bueno SM; Kalergis AM
    Virulence; 2014; 5(7):740-51. PubMed ID: 25513775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathology of RSV: An Updated Review.
    Bergeron HC; Tripp RA
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.